Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2005
10/25/2005US6958321 Isolation, characterization, cloning and use of a mushroom lectin
10/25/2005US6958320 Sel-12 related methods
10/25/2005US6958237 Highly infectious rubella virus DNA constructs and methods of production
10/25/2005US6958236 Control of gene expression in plants
10/25/2005US6958235 Recombinant protein containing a C-terminal fragment of plasmodium MSP-1
10/25/2005US6958224 Chimeric protein α BNAC crystallin with extraordinarily high chaperone-like activity and a method related to the use thereof
10/25/2005US6958223 Methods for producing extracellular matrix proteins
10/25/2005US6958218 Detecting modulators of brain membrane protein; obtain membrane protein, incubate with ligand and labeled compound, measure level of binding
10/25/2005US6958214 Polymorphic kinase anchor proteins and nucleic acids encoding the same
10/25/2005US6958151 Miniprotein ligands and other polypeptides and methods for making and using same
10/25/2005US6958147 Use of VEGF-C to prevent restenosis
10/25/2005CA2252412C Use of the green fluorescent protein as a screenable marker for plant transformation
10/25/2005CA2039165C Plants with modified flowers
10/20/2005WO2005098444A2 Monocarboxylate transporters expressed in cancer cells
10/20/2005WO2005098436A1 A fluorescent polypeptide complex of 40 to 500 nm in size
10/20/2005WO2005098435A2 Peptides and peptidomimetics binding to cd23
10/20/2005WO2005098433A2 Diagnostic assays for alzheimer’s disease
10/20/2005WO2005098051A2 Hsv-2 type-specific immunoassays using glycoprotein g2 peptides
10/20/2005WO2005098043A2 Ligand-dependent protein splicing
10/20/2005WO2005098037A1 Breast cancer signatures
10/20/2005WO2005098015A2 Process for the production of fine chemicals
10/20/2005WO2005098009A2 Synergistic attenutation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
10/20/2005WO2005098008A1 Lipid-diet inducible heart attack murine model
10/20/2005WO2005097998A2 Il-18 specific polypeptides and therapeutic uses thereof
10/20/2005WO2005097997A1 Compositions and methods for inducing anti-tumor immunity
10/20/2005WO2005097996A1 Novel mite allergen
10/20/2005WO2005097995A1 CANCER THERAPY VIA THE INHIBITION OF Skp-2 EXPRESSION
10/20/2005WO2005097994A1 Digoxigenin-binding muteins of the bilin-binding protein of pieris brassicae
10/20/2005WO2005097987A1 Antiinfection vaccine antigen for mucosa-directional human papillomavirus group
10/20/2005WO2005097981A2 Novel herpes simplex viruses
10/20/2005WO2005097829A1 Method for preparing modified collagen outside a host cell
10/20/2005WO2005097828A2 Peptides of cav2.2 that inhibit pain
10/20/2005WO2005097827A1 Method for extracting insulins by improved air-gassing of a folding
10/20/2005WO2005097826A2 Prokineticin 2beta peptide and its use
10/20/2005WO2005097825A2 Bmp-7 variants with improved properties
10/20/2005WO2005097824A2 Cytokinin oxidase sequences and methods of use
10/20/2005WO2005097823A1 Compositions of polypeptides specific to pathogenic strains and their use as vaccines and in immunotherapy
10/20/2005WO2005097822A1 Identification of the precise amino acid sequence of the epitope recognized by the potent neutralizing human anti-hiv-1 monoclonal antibody igg1b12
10/20/2005WO2005097821A1 Optimized expression of hpv 52 l1 in yeast
10/20/2005WO2005097820A1 Peptides for inhibiting mdm2 function
10/20/2005WO2005097818A2 An assay system for screening protease inhibitors
10/20/2005WO2005097205A2 Dna virus microrna and methods for inhibiting same
10/20/2005WO2005097204A1 Preventives/remedies for cancer
10/20/2005WO2005097200A2 Tetanus toxin fusion protein for visualization of active synapses
10/20/2005WO2005097195A2 Methods of reducing aggregation of il-1ra
10/20/2005WO2005097180A1 Dimeric tat antigen and the use thereof for anti-hiv vaccination
10/20/2005WO2005097179A2 Stabilised tat antigen and the use thereof for anti-hiv vaccination
10/20/2005WO2005097175A2 Human glp-1 mimetibodies, compositions, methods and uses
10/20/2005WO2005097171A1 Antiobesity drug
10/20/2005WO2005097168A2 Synthetic chemokines, methods of manufacture, and uses
10/20/2005WO2005097165A2 Il-28 and il-29 cysteine mutants for treating viral infection
10/20/2005WO2005097158A1 Amphipathic glycopeptides
10/20/2005WO2005097156A1 Remedy for neurodegenerative diseases
10/20/2005WO2005096806A1 Rice plant having vaccine gene transferred thereinto
10/20/2005WO2005083431A3 Binding agents
10/20/2005WO2005076827A3 Fbsa compositions for use in promoting fibrinogen aggregation and potentiating fibrin polymerization
10/20/2005WO2005075677A3 Identification of compounds susceptible to induce pidd in cells lacking p53 and their use in combination with genotoxins for the treatment of cancer
10/20/2005WO2005073404A3 Functional element of siah-1b responsive p53
10/20/2005WO2005063800A3 Peptide synthesis using decanting filter
10/20/2005WO2005058945A3 Gene variants coding for proteins from the metabolic pathway of fine chemicals
10/20/2005WO2005056583A3 Plant virus
10/20/2005WO2005052006A3 Mutated anti-cd22 antibodies and immunoconjugates
10/20/2005WO2005051984A3 Methods for producing olfactory gpcrs
10/20/2005WO2005049800A3 Methods for screening for agents capable of modulating t lymphocyte function in response to a herpes simplex virus-infected cell
10/20/2005WO2005049646A3 “seedy1” nuceic acids for making plants having changed growth characteristics
10/20/2005WO2005049641A3 Surface-located campylobacter jejuni polypeptides
10/20/2005WO2005045428A3 Methods and compositions for modulating apoptosis
10/20/2005WO2005040208A3 Peptides derived from heat shock proteins binding toll-like receptors 2 and 4 and their use
10/20/2005WO2005037229A3 Methods and compositions for modulating gamete adhesion
10/20/2005WO2005035760A3 Molecular nanomotor
10/20/2005WO2005030139A3 Seneca valley virus based compositions and methods for treating disease
10/20/2005WO2005028505A3 Multiepitope polypeptides for cancer immunotherapy
10/20/2005WO2005004798A3 Methods for treating lentivirus infections
10/20/2005WO2005000876A3 Ring finger family proteins and uses related thereto
10/20/2005WO2004113528A3 Isoforms of elf-5a: senescence-induced elf5a; wounding-induced elf-5a; growth elf-5a; and dhs
10/20/2005WO2004103389A3 Means for preventing and treating cellular death and their biological applications
10/20/2005WO2004090103A3 Identification of novel nogo-receptors and methods related thereto
10/20/2005WO2004048550A3 Immune response associated proteins
10/20/2005WO2004012660A3 Mk2 interacting proteins
10/20/2005WO2003000863A3 Defensin polynucleotides and methods of use
10/20/2005US20050235382 Plant regulatory sequences for selective control of gene expression
10/20/2005US20050235381 Environmental stress-tolerant plants
10/20/2005US20050235380 Acquired resistance genes in plants
10/20/2005US20050235378 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
10/20/2005US20050235377 Stress tolerant plants and methods thereof
10/20/2005US20050235376 Method for producing a transgenic plant having modified transport of substances
10/20/2005US20050235375 Transcription factors of cereals
10/20/2005US20050235373 IEX-1 knockout animals
10/20/2005US20050235372 Nonhuman model animal unresponsive to immunopotentiating synthetic compound
10/20/2005US20050235371 Noval modified MSP-1 nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems
10/20/2005US20050235367 Regulatory sequences capable of conferring expression of a heterologous DNA sequence in endothelial cells and uses thereof
10/20/2005US20050235366 A transgenic mouse whose genome comprises a transgene encoding metabotropic glutamate receptor 1 (Grm1) operably linked to the melanocyte-specific promoter expresses the Grm 1 in melanocytes, develops lesions on hairless skin, and lacks pigmentation; screening anticarcinogenic agents; medical diagonosis
10/20/2005US20050235365 Helicokinin-receptor from insects
10/20/2005US20050234230 formed via reductive amination with O-[2-(2-aminooxy-ethoxy)-ethyl]-hydroxyl amine; conjugated to erythropoietin
10/20/2005US20050234228 Novel human seven transmembrane proteins and polynucleotides encoding the same
10/20/2005US20050234227 Ribosome structure and protein synthesis inhibitors
10/20/2005US20050234226 Persephin and related growth factors
10/20/2005US20050234223 Drug candidate compounds such as H3 receptor inverse agonists can be screened more easily and efficiently
10/20/2005US20050234221 genetic vectors, host cells and nucleotide sequences that code polypeptides, agonists and antagonists, that preferentially bind to interleukins, used for diagnosis oro prophylaxis of diseases
10/20/2005US20050234005 Cloning and expression of the full length 110 KDa antigen of Orientia tsutsugamushi to be used as a vaccine component against scrub typhus
1 ... 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 ... 2916